Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate mutase family member 4 pseudogene 2 (PGAM4P2) is a pseudogene in the human genome, related to the phosphoglycerate mutase family, specifically the member 4 gene (PGAM4)[1][4][7]. As a pseudogene, PGAM4P2 does not encode a functional protein and is generally considered transcriptionally inactive or only transcribed as noncoding RNA; pseudogenes can sometimes regulate their parental genes through various RNA-mediated mechanisms, but no such function is specifically described or validated for PGAM4P2[1][2][7]. PGAM4P2 is not recognized as a therapeutic target, and there is no current evidence linking it directly to disease processes, biomarker roles, or drug interactions[1][4][7]. It is best classified as a processed or duplicated pseudogene, distinguished by sequence similarity to the enzymatically active phosphoglycerate mutase genes but lacking protein-coding capacity due to genomic alterations typical of pseudogenes[1][2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate mutase family member 4 pseudogene 2 (PGAM4P2).